We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+1.73%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$148M
AUM Growth
+$7.27M
Cap. Flow
+$7.5M
Cap. Flow %
5.05%
Top 10 Hldgs %
41.04%
Holding
73
New
3
Increased
35
Reduced
7
Closed
5

Top Buys

Rank Stock Value
1
TEAR
TearLab Corporation
TEAR
+$4.27M
2
VCRA
VOCERA COMMUNICATIONS, INC.
VCRA
+$3.69M
3
NEO icon
NeoGenomics
NEO
+$1.89M
4
ITMN
INTERMUNE INC
ITMN
+$1.28M
5
ATRC icon
AtriCure
ATRC
+$410K

Top Sells

Rank Stock Value
1
STKL
SunOpta
STKL
+$1.76M
2
MASI
Masimo
MASI
+$1.42M
3
OREX
Orexigen Therapeutics, Inc.
OREX
+$1.27M
4
HTWR
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
+$986K
5
THOR
THORATEC CORPORATION
THOR
+$867K

Sector Composition

Rank Sector Weight
1 Healthcare 82.86%
2 Technology 2.4%
3 Consumer Staples 1.11%
4 Financials 0.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LAB icon
26
Standard BioTools
LAB
$340M
$2.13M 1.44%
72,451
+4,036
+6% +$129K
GNMK
27
DELISTED
GenMark Diagnostics, Inc
GNMK
$2.03M 1.37%
150,076
+8,952
+6% +$93.4K
LMAT icon
28
LeMaitre Vascular
LMAT
$2.32B
$1.95M 1.32%
236,262
+12,853
+6% +$100K
CPHD
29
DELISTED
Cepheid Inc
CPHD
$1.92M 1.3%
40,132
-11,995
-23% -$544K
ALGN icon
30
Align Technology
ALGN
$12.1B
$1.85M 1.25%
33,036
+1,690
+5% +$87.9K
ABCO
31
DELISTED
Advisory Board Co
ABCO
$1.83M 1.23%
35,254
+1,927
+6% +$104K
HSTM icon
32
HealthStream
HSTM
$819M
$1.8M 1.21%
73,921
+4,030
+6% +$100K
SGNT
33
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$1.77M 1.2%
68,654
+3,798
+6% +$84.4K
STKL
34
DELISTED
SunOpta
STKL
$1.65M 1.11%
117,470
-141,516
-55% -$1.76M
COV
35
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$1.62M 1.09%
17,992
+979
+6% +$73.2K
ITMN
36
DELISTED
INTERMUNE INC
ITMN
$1.54M 1.04%
+34,834
New +$1.28M
VRTX icon
37
Vertex Pharmaceuticals
VRTX
$121B
$1.5M 1.01%
15,849
+859
+6% +$60.2K
ELGX
38
DELISTED
Endologix Inc
ELGX
$1.41M 0.95%
9,285
+509
+6% +$67.7K
BMRN icon
39
BioMarin Pharmaceuticals
BMRN
$11.6B
$1.23M 0.83%
19,752
+1,063
+6% +$64.2K
ANGO icon
40
AngioDynamics
ANGO
$611M
$1.11M 0.75%
67,769
+3,509
+5% +$50.8K
PETX
41
DELISTED
Aratana Therapeutics, Inc.
PETX
$815K 0.55%
52,234
+2,971
+6% +$42.1K
CYTK icon
42
Cytokinetics
CYTK
$10.5B
$772K 0.52%
161,571
+8,233
+5% +$50.2K
SURG
43
DELISTED
SYNERGETICS USA, INC.
SURG
$717K 0.48%
231,425
-41,426
-15% -$137K
FRX
44
DELISTED
FOREST LABORATORIES INC
FRX
$610K 0.41%
6,157
-1,478
-19% -$138K
ENDP
45
DELISTED
Endo International plc
ENDP
$571K 0.38%
8,161
-964
-11% -$64.5K
NVS icon
46
Novartis
NVS
$297B
$550K 0.37%
6,774
– –
VTRS icon
47
Viatris
VTRS
$20.4B
$504K 0.34%
9,775
– –
HUM icon
48
Humana
HUM
$43.7B
$452K 0.3%
3,540
– –
ELV icon
49
Elevance Health
ELV
$81.5B
$441K 0.3%
4,095
– –
AET
50
DELISTED
Aetna Inc
AET
$423K 0.29%
5,215
– –
1
2
3

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q2 2014 Portfolio in Review

As of Q2 2014, First Light Asset Management held 73 positions worth $148M, up 5.1% from $141M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

First Light Asset Management deployed $7.5M of net new capital in Q2 2014, opening 3 new positions and adding to 35 existing holdings. Its largest new stake was TearLab Corporation: 87,413 shares worth $4.26M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 86% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was SunOpta, an estimated $1.76M trimmed.

  • First Light Asset Management's largest Q2 2014 buy was TearLab Corporation: 87,413 shares worth $4.26M.
  • First Light Asset Management added most to NeoGenomics in Q2 2014, an estimated $1.89M increase.
  • First Light Asset Management's biggest Q2 2014 reduction was SunOpta, cutting an estimated $1.76M.
  • First Light Asset Management fully exited Masimo in Q2 2014, selling an estimated $1.42M.
  • First Light Asset Management's ten largest holdings make up 41% of its $148M portfolio in Q2 2014.
  • First Light Asset Management opened 3 new positions and closed 5 in Q2 2014.
  • First Light Asset Management's portfolio value rose 5.1% quarter-over-quarter to $148M.

Based on First Light Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.